Lv6
2790 积分 2022-09-24 加入
Safety and Pharmacokinetics of Single‐Dose Mirikizumab in Chinese Healthy Participants: Results From a Phase 1 Study
1个月前
已完结
Safety and efficacy of mirikizumab versus secukinumab and placebo in the treatment of moderate-to-severe plaque psoriasis (OASIS-2): a phase 3, multicentre, randomised, double-blind study
1个月前
已完结
Efficacy and safety of mirikizumab in psoriasis: results from a 52-week, double-blind, placebo-controlled, randomized withdrawal, phase III trial (OASIS-1)
1个月前
已完结
Higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's disease
2个月前
已完结
IL-17A inhibitor-induced ulcerative colitis treated with an anti-IL-23 antibody
3个月前
已完结
Case Report: Secukinumab (Interleukin-17 Inhibitor) and Ulcerative Colitis Flare - the Double-Edged Sword
3个月前
已完结
Secukinumab-induced ulcerative colitis in a patient with psoriasis successfully treated with risankizumab
3个月前
已完结
A modified Kirby-Bauer disc diffusion (mKB) method for accurately testing tigecycline susceptibility: a nation-wide multicenter comparative study
4个月前
已完结
Association of Interleukin-23R Gene Polymorphisms with Behcet’s Disease Susceptibility: A Meta-Analysis of Case-control Studies
4个月前
已完结
Non-HLA Genetic Polymorphisms of Interleukin-17 and Interleukin-23 Receptor in Behcet’s Syndrome
4个月前
已完结